PATENT CLAIM ANALYSIS

Application Number: 15741326
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "006900"]

Abstract:
The present invention relates to methods for identifying, assessing, preventing, and treating metabolic disorders and modulating metabolic processes using Slit2.

Claim (Index 37):
A method for assessing the efficacy of an agent that modulates Slit2 expression and/or activity for modulating a metabolic response in a subject, comprising:\n a) detecting in a subject sample at a first point in time, the expression and/or activity of Slit2; b) repeating step a) during at least one subsequent point in time after administration of the agent; and c) comparing the expression and/or activity detected in steps a) and b), wherein a significantly lower expression and/or activity of a marker listed in Table 1 or 2 in the first subject sample relative to at least one subsequent subject sample, indicates that the agent increases the metabolic response in the subject and/or wherein a significantly higher expression and/or activity of a marker listed in Table 1 or 2 in the first subject sample relative to at least one subsequent subject sample, indicates that the test agent decreases the metabolic response in the subject.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13611641', '12446110', '15124795', '14344460', '13143645']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7972787305320336
- 35 USC 102 Novelty (BERT): 0.5284250616796828
- Combined Prediction Score: 0.7703933636467984
- Mean Citation Score: 326.529336
- Max Citation Score: 342.2282
- Similarity Product: 195.6766992811203

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test